Modular Lysosome-Targeting Platform Based on a Multivalent DNA Framework for Programmable Protein Degradation.
This work develops a tetrahedral DNA nanostructure-based multivalent lysosome-targeting antibody platform (TDN-MLYTAB) and demonstrates how programmable DNA nanostructures can overcome persistent bioconjugation challenges, advancing modular therapeutics toward application.